| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.4 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.4 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.4 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |